{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:53:27Z","timestamp":1790225607609,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cell.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Microbiology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.tim.2018.06.005","type":"journal-article","created":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T23:52:16Z","timestamp":1532044336000},"page":"26-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":102,"title":["Can \u03b2-Lactam Antibiotics Be Resurrected to Combat MRSA?"],"prefix":"10.1016","volume":"27","author":[{"given":"Timothy J.","family":"Foster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tim.2018.06.005_bib0005","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.mib.2010.09.008","article-title":"The future of the beta-lactams","volume":"13","author":"Llarrull","year":"2010","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.tim.2018.06.005_bib0010","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nrmicro2200","article-title":"Waves of resistance: Staphylococcus aureus in the antibiotic era","volume":"7","author":"Chambers","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.tim.2018.06.005_bib0015","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1146\/annurev-biochem-060614-034516","article-title":"Mechanisms of methicillin resistance in Staphylococcus aureus","volume":"84","author":"Peacock","year":"2015","journal-title":"Annu. Rev. Biochem."},{"issue":"Suppl. 1","key":"10.1016\/j.tim.2018.06.005_bib0020","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1093\/cid\/cit613","article-title":"Methicillin-resistant Staphylococcus aureus: an evolving pathogen","volume":"58","author":"Stryjewski","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.tim.2018.06.005_bib0025","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1146\/annurev.micro.112408.134309","article-title":"Basis of virulence in community-associated methicillin-resistant Staphylococcus aureus","volume":"64","author":"Otto","year":"2010","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.tim.2018.06.005_bib0030","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/1469-0691.12705","article-title":"New epidemiology of Staphylococcus aureus infection in Asia","volume":"20","author":"Chen","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.tim.2018.06.005_bib0035","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1128\/CMR.00037-09","article-title":"Three decades of beta-lactamase inhibitors","volume":"23","author":"Drawz","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.tim.2018.06.005_bib0040","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.chembiol.2012.11.013","article-title":"Discovery of wall teichoic acid inhibitors as potential anti-MRSA beta-lactam combination agents","volume":"20","author":"Wang","year":"2013","journal-title":"Chem. Biol."},{"key":"10.1016\/j.tim.2018.06.005_bib0045","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.cell.2017.10.012","article-title":"Membrane microdomain disassembly inhibits MRSA antibiotic resistance","volume":"171","author":"Garcia-Fernandez","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.tim.2018.06.005_bib0050","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00863-17","article-title":"beta-Lactam antibiotics with a high affinity for PBP2 act synergistically with the FtsZ-targeting agent TXA707 against methicillin-resistant Staphylococcus aureus","volume":"61","author":"Ferrer-Gonzalez","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tim.2018.06.005_bib0055","doi-asserted-by":"crossref","first-page":"6192","DOI":"10.1128\/AAC.01525-12","article-title":"beta-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives","volume":"56","author":"Mehta","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tim.2018.06.005_bib0060","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01634-16","article-title":"Molecular bases determining daptomycin resistance-mediated resensitization to beta-lactams (seesaw effect) in methicillin-resistant Staphylococcus aureus","volume":"61","author":"Renzoni","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tim.2018.06.005_bib0065","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/mmi.13696","article-title":"Assembly and activation of the Escherichia coli divisome","volume":"105","author":"Du","year":"2017","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.tim.2018.06.005_bib0070","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/cm.21054","article-title":"Bacterial cytokinesis: from Z ring to divisome","volume":"69","author":"Lutkenhaus","year":"2012","journal-title":"Cytoskeleton (Hoboken)"},{"key":"10.1016\/j.tim.2018.06.005_bib0075","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nature25506","article-title":"Peptidoglycan synthesis drives an FtsZ-treadmilling-independent step of cytokinesis","volume":"554","author":"Monteiro","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.tim.2018.06.005_bib0080","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1007\/s00018-005-5148-6","article-title":"Beta-lactam resistance in Staphylococcus aureus: the adaptive resistance of a plastic genome","volume":"62","author":"Fuda","year":"2005","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.tim.2018.06.005_bib0085","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1365-2958.2009.06687.x","article-title":"Evidence for a dual role of PBP1 in the cell division and cell separation of Staphylococcus aureus","volume":"72","author":"Pereira","year":"2009","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.tim.2018.06.005_bib0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004891","article-title":"Staphylococcus aureus survives with a minimal peptidoglycan synthesis machine but sacrifices virulence and antibiotic resistance","volume":"11","author":"Reed","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.tim.2018.06.005_bib0095","doi-asserted-by":"crossref","first-page":"10886","DOI":"10.1073\/pnas.191260798","article-title":"An acquired and a native penicillin-binding protein cooperate in building the cell wall of drug-resistant staphylococci","volume":"98","author":"Pinho","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tim.2018.06.005_bib0100","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1128\/AAC.00049-08","article-title":"Staphylococcus aureus PBP4 is essential for beta-lactam resistance in community-acquired methicillin-resistant strains","volume":"52","author":"Memmi","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tim.2018.06.005_bib0105","first-page":"870","article-title":"Structural basis for the beta lactam resistance of PBP2a from methicillin-resistant Staphylococcus aureus","volume":"9","author":"Lim","year":"2002","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.tim.2018.06.005_bib0110","doi-asserted-by":"crossref","first-page":"16808","DOI":"10.1073\/pnas.1300118110","article-title":"How allosteric control of Staphylococcus aureus penicillin binding protein 2a enables methicillin resistance and physiological function","volume":"110","author":"Otero","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Suppl. 3","key":"10.1016\/j.tim.2018.06.005_bib0115","first-page":"iii11","article-title":"Ceftaroline fosamil: a new broad-spectrum cephalosporin","volume":"66","author":"Laudano","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.tim.2018.06.005_bib0120","doi-asserted-by":"crossref","first-page":"18909","DOI":"10.1073\/pnas.1209126109","article-title":"Methicillin resistance in Staphylococcus aureus requires glycosylated wall teichoic acids","volume":"109","author":"Brown","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tim.2018.06.005_bib0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006674","article-title":"Evidence for the evolutionary steps leading to mecA-mediated beta-lactam resistance in staphylococci","volume":"13","author":"Rolo","year":"2017","journal-title":"PLoS Genet."},{"key":"10.1016\/j.tim.2018.06.005_bib0130","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02302-16","article-title":"Evolutionary origin of the staphylococcal cassette chromosome mec (SCCmec)","volume":"61","author":"Rolo","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tim.2018.06.005_bib0135","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1128\/AAC.02333-15","article-title":"The Staphylococcus aureus chaperone PrsA is a new auxiliary factor of oxacillin resistance affecting penicillin-binding protein 2A","volume":"60","author":"Jousselin","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tim.2018.06.005_bib0140","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jacc.2014.06.1159","article-title":"2013 ACC\/AHA guideline recommends fixed-dose strategies instead of targeted goals to lower blood cholesterol","volume":"64","author":"Smith","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.tim.2018.06.005_bib0145","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pharmthera.2006.03.003","article-title":"Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug\u2013drug interactions and interindividual differences in transporter and metabolic enzyme functions","volume":"112","author":"Shitara","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.tim.2018.06.005_bib0150","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1128\/AAC.00192-16","article-title":"Is there potential for repurposing statins as novel antimicrobials?","volume":"60","author":"Hennessy","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tim.2018.06.005_bib0155","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jcrc.2010.02.013","article-title":"The effect of statins on mortality from severe infections and sepsis: a systematic review and meta-analysis","volume":"25","author":"Janda","year":"2010","journal-title":"J. Crit. Care"},{"key":"10.1016\/j.tim.2018.06.005_bib0160","doi-asserted-by":"crossref","first-page":"e51548","DOI":"10.1371\/journal.pone.0051548","article-title":"Systematic review and meta-analysis on the association between outpatient statins use and infectious disease-related mortality","volume":"7","author":"Ma","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.tim.2018.06.005_bib0165","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02228-16","article-title":"Evidence to support continuation of statin therapy in patients with Staphylococcus aureus bacteremia","volume":"61","author":"Caffrey","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tim.2018.06.005_bib0170","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1164\/rccm.201209-1718OC","article-title":"A multicenter randomized trial of atorvastatin therapy in intensive care patients with severe sepsis","volume":"187","author":"Kruger","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.tim.2018.06.005_bib0175","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/sur.2006.077","article-title":"Statin (cerivastatin) protects mice against sepsis-related death via reduced proinflammatory cytokines and enhanced bacterial clearance","volume":"9","author":"Chaudhry","year":"2008","journal-title":"Surg. Infect. (Larchmt)"},{"key":"10.1016\/j.tim.2018.06.005_bib0180","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.atherosclerosis.2005.12.022","article-title":"Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo","volume":"189","author":"Niessner","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.tim.2018.06.005_bib0185","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(98)05917-0","article-title":"Inhibition of proinflammatory cytokine production by pravastatin","volume":"353","author":"Rosenson","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.tim.2018.06.005_bib0190","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.chom.2010.10.005","article-title":"Statins enhance formation of phagocyte extracellular traps","volume":"8","author":"Chow","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.tim.2018.06.005_bib0195","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1126\/science.1153018","article-title":"A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence","volume":"319","author":"Liu","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.tim.2018.06.005_bib0200","doi-asserted-by":"crossref","first-page":"4950","DOI":"10.1128\/IAI.00204-06","article-title":"Staphyloxanthin plays a role in the fitness of Staphylococcus aureus and its ability to cope with oxidative stress","volume":"74","author":"Clauditz","year":"2006","journal-title":"Infect. Immun."},{"key":"10.1016\/j.tim.2018.06.005_bib0205","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1101\/gad.1945010","article-title":"Functional microdomains in bacterial membranes","volume":"24","author":"Lopez","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.tim.2018.06.005_bib0210","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1126\/science.1159961","article-title":"An inhibitor of FtsZ with potent and selective anti-staphylococcal activity","volume":"321","author":"Haydon","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.tim.2018.06.005_bib0215","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1128\/AAC.00708-15","article-title":"TXA709, an FtsZ-targeting benzamide prodrug with improved pharmacokinetics and enhanced in vivo efficacy against methicillin-resistant Staphylococcus aureus","volume":"59","author":"Kaul","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tim.2018.06.005_bib0220","doi-asserted-by":"crossref","first-page":"126ra35","DOI":"10.1126\/scitranslmed.3003592","article-title":"Restoring methicillin-resistant Staphylococcus aureus susceptibility to beta-lactam antibiotics","volume":"4","author":"Tan","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tim.2018.06.005_bib0225","doi-asserted-by":"crossref","first-page":"4290","DOI":"10.1128\/AAC.00613-16","article-title":"Combining the FtsZ-targeting prodrug TXA709 and the cephalosporin cefdinir confers synergy and reduces the frequency of resistance in methicillin-resistant Staphylococcus aureus","volume":"60","author":"Kaul","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tim.2018.06.005_bib0230","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1021\/acschembio.7b00323","article-title":"Structural flexibility of an inhibitor overcomes drug resistance mutations in Staphylococcus aureus FtsZ","volume":"12","author":"Fujita","year":"2017","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.tim.2018.06.005_bib0235","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.1128\/AAC.00726-12","article-title":"Broadening the spectrum of beta-lactam antibiotics through inhibition of signal peptidase type I","volume":"56","author":"Therien","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tim.2018.06.005_bib0240","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1128\/MMBR.67.4.686-723.2003","article-title":"A continuum of anionic charge: structures and functions of D-alanyl-teichoic acids in gram-positive bacteria","volume":"67","author":"Neuhaus","year":"2003","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.tim.2018.06.005_bib0245","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nrmicro1861","article-title":"Teichoic acids and related cell-wall glycopolymers in Gram-positive physiology and host interactions","volume":"6","author":"Weidenmaier","year":"2008","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.tim.2018.06.005_bib0250","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.mib.2013.06.014","article-title":"Teichoic acid biosynthesis as an antibiotic target","volume":"16","author":"Pasquina","year":"2013","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.tim.2018.06.005_bib0255","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/cbic.200900557","article-title":"Wall teichoic acid function, biosynthesis, and inhibition","volume":"11","author":"Swoboda","year":"2010","journal-title":"ChemBioChem"},{"key":"10.1016\/j.tim.2018.06.005_bib0260","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nm991","article-title":"Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections","volume":"10","author":"Weidenmaier","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.tim.2018.06.005_bib0265","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/ja.2013.100","article-title":"Taking aim at wall teichoic acid synthesis: new biology and new leads for antibiotics","volume":"67","author":"Sewell","year":"2014","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.tim.2018.06.005_bib0270","doi-asserted-by":"crossref","first-page":"18991","DOI":"10.1073\/pnas.1004304107","article-title":"Teichoic acids are temporal and spatial regulators of peptidoglycan cross-linking in Staphylococcus aureus","volume":"107","author":"Atilano","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tim.2018.06.005_bib0275","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1021\/cb100269f","article-title":"Synthetic lethal compound combinations reveal a fundamental connection between wall teichoic acid and peptidoglycan biosyntheses in Staphylococcus aureus","volume":"6","author":"Campbell","year":"2011","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.tim.2018.06.005_bib0280","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1021\/cb900151k","article-title":"Discovery of a small molecule that blocks wall teichoic acid biosynthesis in Staphylococcus aureus","volume":"4","author":"Swoboda","year":"2009","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.tim.2018.06.005_bib0285","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1021\/cb300413m","article-title":"Inhibition of WTA synthesis blocks the cooperative action of PBPs and sensitizes MRSA to beta-lactams","volume":"8","author":"Farha","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.tim.2018.06.005_bib0290","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1093\/humrep\/dei042","article-title":"Clomiphene citrate \u2013 end of an era? A mini-review","volume":"20","author":"Homburg","year":"2005","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.tim.2018.06.005_bib0295","doi-asserted-by":"crossref","first-page":"11048","DOI":"10.1073\/pnas.1511751112","article-title":"Antagonism screen for inhibitors of bacterial cell wall biogenesis uncovers an inhibitor of undecaprenyl diphosphate synthase","volume":"112","author":"Farha","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tim.2018.06.005_bib0300","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1021\/acsmedchemlett.7b00285","article-title":"Targeting wall teichoic acid in situ with branched polyethylenimine potentiates beta-lactam efficacy against MRSA","volume":"8","author":"Foxley","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.tim.2018.06.005_bib0305","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1021\/acsinfecdis.7b00056","article-title":"Human microbiome inspired antibiotics with improved beta-lactam synergy against MDR Staphylococcus aureus","volume":"4","author":"Chu","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.tim.2018.06.005_bib0310","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.chembiol.2009.05.012","article-title":"Chemical genetic identification of peptidoglycan inhibitors potentiating carbapenem activity against methicillin-resistant Staphylococcus aureus","volume":"16","author":"Huber","year":"2009","journal-title":"Chem. Biol."},{"key":"10.1016\/j.tim.2018.06.005_bib0315","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026997","article-title":"Mechanism of action and resistance to daptomycin in Staphylococcus aureus and enterococci","volume":"6","author":"Miller","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.tim.2018.06.005_bib0320","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1749-6632.2012.06819.x","article-title":"Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall","volume":"1277","author":"Bayer","year":"2013","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.tim.2018.06.005_bib0325","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/cid\/cir764","article-title":"Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study","volume":"54","author":"Moore","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.tim.2018.06.005_bib0330","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijid.2017.07.019","article-title":"Beta-lactam combination therapy for the treatment of Staphylococcus aureus and Enterococcus species bacteremia: a summary and appraisal of the evidence","volume":"63","author":"Bartash","year":"2017","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.tim.2018.06.005_bib0335","doi-asserted-by":"crossref","unstructured":"Tong, S.Y. et al., and group Cs, the Australasian Society for Infectious Diseases Clinical Research N (2016) CAMERA2 \u2013 combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial. Trials 17, 170","DOI":"10.1186\/s13063-016-1295-3"},{"key":"10.1016\/j.tim.2018.06.005_bib0340","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1128\/AAC.02071-15","article-title":"Penicillin binding protein 1 is important in the compensatory response of Staphylococcus aureus to daptomycin-induced membrane damage and is a potential target for beta-lactam-daptomycin synergy","volume":"60","author":"Berti","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tim.2018.06.005_bib0345","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1128\/AAC.00594-13","article-title":"beta-Lactam antibiotics targeting PBP1 selectively enhance daptomycin activity against methicillin-resistant Staphylococcus aureus","volume":"57","author":"Berti","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tim.2018.06.005_bib0350","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1128\/IAI.73.4.2411-2423.2005","article-title":"Staphylococcus aureus deficient in lipidation of prelipoproteins is attenuated in growth and immune activation","volume":"73","author":"Stoll","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.tim.2018.06.005_bib0355","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1128\/AAC.06264-11","article-title":"The posttranslocational chaperone lipoprotein PrsA is involved in both glycopeptide and oxacillin resistance in Staphylococcus aureus","volume":"56","author":"Jousselin","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tim.2018.06.005_bib0360","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/cid\/cir340","article-title":"Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding","volume":"53","author":"Dhand","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.tim.2018.06.005_bib0365","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1128\/AAC.02192-12","article-title":"Multicenter evaluation of the clinical outcomes of daptomycin with and without concomitant beta-lactams in patients with Staphylococcus aureus bacteremia and mild to moderate renal impairment","volume":"57","author":"Moise","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tim.2018.06.005_bib0370","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1128\/AAC.00088-14","article-title":"Evaluation of ceftaroline, vancomycin, daptomycin, or ceftaroline plus daptomycin against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro pharmacokinetic\/pharmacodynamic model of simulated endocardial vegetations","volume":"58","author":"Werth","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tim.2018.06.005_bib0375","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.1128\/AAC.00386-15","article-title":"Evaluation of ceftaroline alone and in combination against biofilm-producing methicillin-resistant Staphylococcus aureus with reduced susceptibility to daptomycin and vancomycin in an in vitro pharmacokinetic\/pharmacodynamic model","volume":"59","author":"Barber","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tim.2018.06.005_bib0380","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1128\/AAC.01586-12","article-title":"Ceftaroline increases membrane binding and enhances the activity of daptomycin against daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus in a pharmacokinetic\/pharmacodynamic model","volume":"57","author":"Werth","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tim.2018.06.005_bib0385","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.clinthera.2014.05.061","article-title":"Antimicrobial salvage therapy for persistent staphylococcal bacteremia using daptomycin plus ceftaroline","volume":"36","author":"Sakoulas","year":"2014","journal-title":"Clin. Ther."},{"key":"10.1016\/j.tim.2018.06.005_bib0390","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026989","article-title":"Approved glycopeptide antibacterial drugs: mechanism of action and resistance","volume":"6","author":"Zeng","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.tim.2018.06.005_bib0395","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1128\/CMR.00042-09","article-title":"Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications","volume":"23","author":"Howden","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.tim.2018.06.005_bib0400","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1172\/JCI68834","article-title":"Mechanisms of vancomycin resistance in Staphylococcus aureus","volume":"124","author":"Gardete","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tim.2018.06.005_bib0405","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.drup.2013.10.002","article-title":"Reduced glycopeptide and lipopeptide susceptibility in Staphylococcus aureus and the \u2018seesaw effect\u2019: taking advantage of the back door left open?","volume":"16","author":"Ortwine","year":"2013","journal-title":"Drug Resist. Update"},{"key":"10.1016\/j.tim.2018.06.005_bib0410","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s10096-013-1817-9","article-title":"Combinations of cefoxitin plus other beta-lactams are synergistic in vitro against community associated methicillin-resistant Staphylococcus aureus","volume":"32","author":"Banerjee","year":"2013","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.tim.2018.06.005_bib0415","doi-asserted-by":"crossref","first-page":"6154","DOI":"10.1038\/s41598-017-06329-2","article-title":"Role of SCCmec type in resistance to the synergistic activity of oxacillin and cefoxitin in MRSA","volume":"7","author":"Reichmann","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tim.2018.06.005_bib0420","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/nchembio.1911","article-title":"Synergistic, collaterally sensitive beta-lactam combinations suppress resistance in MRSA","volume":"11","author":"Gonzales","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.tim.2018.06.005_bib0425","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00109-013-1100-7","article-title":"Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus","volume":"92","author":"Sakoulas","year":"2014","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.tim.2018.06.005_bib0430","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/infdis\/jiw461","article-title":"Redeploying beta-lactam antibiotics as a novel antivirulence strategy for the treatment of methicillin-resistant Staphylococcus aureus infections","volume":"215","author":"Waters","year":"2017","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tim.2018.06.005_bib0435","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1128\/AAC.04767-14","article-title":"Novel quorum-quenching agents promote methicillin-resistant Staphylococcus aureus (MRSA) wound healing and sensitize MRSA to beta-lactam antibiotics","volume":"59","author":"Kuo","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tim.2018.06.005_bib0440","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/infdis\/jiw464","article-title":"Redeploying beta-lactams against Staphylococcus aureus: repurposing with a purpose","volume":"215","author":"Bayer","year":"2017","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tim.2018.06.005_bib0445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002229","article-title":"Evolutionary trade-offs underlie the multi-faceted virulence of Staphylococcus aureus","volume":"13","author":"Laabei","year":"2015","journal-title":"PLoS Biol."},{"key":"10.1016\/j.tim.2018.06.005_bib0450","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1520255113","article-title":"Natural mutations in a Staphylococcus aureus virulence regulator attenuate cytotoxicity but permit bacteremia and abscess formation","volume":"113","author":"Das","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Trends in Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966842X18301409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966842X18301409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T17:06:33Z","timestamp":1545066393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966842X18301409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":90,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0966842X18301409"],"URL":"https:\/\/doi.org\/10.1016\/j.tim.2018.06.005","relation":{},"ISSN":["0966-842X"],"issn-type":[{"value":"0966-842X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can \u03b2-Lactam Antibiotics Be Resurrected to Combat MRSA?","name":"articletitle","label":"Article Title"},{"value":"Trends in Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tim.2018.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}